Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy.
Maria Lee, Chel Hun Choi, Yi Kyeong Chun...
https://pubmed.ncbi.nlm.nih.gov/27670259/Actively Recruiting
Led by CHA University · Updated on 2025-04-09
240
Participants Needed
26
Research Sites
N/A
Total Duration
Researchers are evaluating the therapeutic effect of surgical debulking of bulky or multiple lymph nodes before concurrent chemoradiation therapy CCRT in women with cervical cancer stage IIICr. This prospective, multicenter, randomized clinical trial DEBULK trial aims to compare outcomes between surgical debulking plus CCRT and CCRT alone, addressing challenges posed by lymph node metastasis that can reduce radiotherapy effectiveness. The study includes two groups one receiving CCRT only, and the other undergoing surgical removal of bulky or multiple lymph nodes followed by CCRT. This phase III trial is conducted across multiple centers, assessing the impact of adding surgery prior to standard chemoradiation treatment on patient outcomes. Participants will be monitored through clinical evaluations including imaging to assess lymph node status, and follow-up for three years to measure progression-free survival as the primary outcome. Secondary outcomes include overall survival, treatment-related complications, and accuracy of lymph node imaging. The study involves informed consent, radiological assessments, and regular follow-ups to collect these data until the study ends in 2030.
CONDITIONS
Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr
J
Ju-Won Roh
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
CHA University
Lead Sponsor
Korean Gynecologic Oncology Group
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 week
Participants undergo surgical debulking of bulky or multiple lymph nodes if assigned to the experimental group.
1 surgery visit and several immediate post-operative visits
Duration - Duration as per standard CCRT schedule
Participants receive concurrent chemoradiation therapy (CCRT) following surgery or as the primary treatment if assigned to the control group.
Multiple visits for chemoradiation therapy over several weeks
Duration - Up to 3 years
Participants are followed to monitor progression-free survival, overall survival, and treatment-related complications.
Periodic follow-up visits during 3 years
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Maria Lee, Chel Hun Choi, Yi Kyeong Chun...
https://pubmed.ncbi.nlm.nih.gov/27670259/Nadeem R Abu-Rustum, Catheryn M Yashar, Sarah Bean...
https://pubmed.ncbi.nlm.nih.gov/32502976/Luigi Pedone Anchora, Vittoria Carbone, Valerio Gallotta...
https://pubmed.ncbi.nlm.nih.gov/32545508/P Suprasert, J Srisomboon, K Charoenkwan...
https://pubmed.ncbi.nlm.nih.gov/15882176/Jung-Woo Park, Jong Woon Bae
https://pubmed.ncbi.nlm.nih.gov/27284443/N Devoogdt, H Lemkens, I Geraerts...
https://pubmed.ncbi.nlm.nih.gov/20924341/N Sakuragi, C Satoh, N Takeda...
https://pubmed.ncbi.nlm.nih.gov/10193945/Jie Yang, Ritchie Delara, Javier Magrina...
https://pubmed.ncbi.nlm.nih.gov/31843274/Jay W Carlson, James Kauderer, Alan Hutson...
https://pubmed.ncbi.nlm.nih.gov/31837831/Tatsuya Kato, Hidemichi Watari, Mahito Takeda...
https://pubmed.ncbi.nlm.nih.gov/23875071/CHA University
Lead Sponsor
Korean Gynecologic Oncology Group
Collaborating Sponsor